MXPA05011826A - Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46. - Google Patents

Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46.

Info

Publication number
MXPA05011826A
MXPA05011826A MXPA05011826A MXPA05011826A MXPA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A MX PA05011826 A MXPA05011826 A MX PA05011826A
Authority
MX
Mexico
Prior art keywords
amino acid
monoclonal antibody
antibody binding
probnp
native probnp
Prior art date
Application number
MXPA05011826A
Other languages
English (en)
Inventor
Christoph Seidel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33427054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05011826(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA05011826A publication Critical patent/MXPA05011826A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion se refiere a anticuerpos que se enlazan a proBNP nativo, un metodo para deteccion especifica de proBNP nativo, un metodo para correlacionar el nivel de proBNP nativo para el diagnostico de insuficiencia cardiaca, un kit para deteccion de proBNP nativo y a una linea de celulas de hibridoma que produce un anticuerpo para porBNP nativo.
MXPA05011826A 2003-05-12 2004-05-12 Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46. MXPA05011826A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03010591 2003-05-12
PCT/EP2004/005092 WO2004099253A1 (en) 2003-05-12 2004-05-12 Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46

Publications (1)

Publication Number Publication Date
MXPA05011826A true MXPA05011826A (es) 2006-01-26

Family

ID=33427054

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011826A MXPA05011826A (es) 2003-05-12 2004-05-12 Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46.

Country Status (16)

Country Link
US (4) US7264938B2 (es)
EP (4) EP1625163B8 (es)
JP (4) JP5128125B2 (es)
KR (2) KR100857752B1 (es)
CN (3) CN1784425A (es)
AT (2) ATE517124T1 (es)
AU (1) AU2004235974B2 (es)
BR (1) BRPI0410261B8 (es)
CA (2) CA2522378C (es)
DK (3) DK1625164T3 (es)
ES (3) ES2372282T3 (es)
HK (1) HK1097855A1 (es)
HU (1) HUE025169T2 (es)
MX (1) MXPA05011826A (es)
PL (3) PL1625164T3 (es)
WO (2) WO2004099252A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
ES2372282T3 (es) * 2003-05-12 2012-01-18 F. Hoffmann-La Roche Ag Método para detectar probnp con un anticuerpo monoclonal que fija los aminoácidos 38-43.
WO2004105575A2 (en) * 2003-05-29 2004-12-09 Trustee Of Darmouth College A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
DE10355731A1 (de) * 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP
ATE364177T1 (de) * 2004-07-07 2007-06-15 Hoffmann La Roche Kombinationen von markern zum nachweis von typ 1 und 2 diabetes
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
DK2115477T3 (en) 2007-01-25 2015-08-10 Hoffmann La Roche USE OF IGFBP-7 IN THE EVIDENCE OF HEART FAILURE
KR100836322B1 (ko) * 2007-08-31 2008-06-09 현대자동차주식회사 차량용 흡음재 제작장치 및 방법
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
ES2526928T3 (es) 2008-04-30 2015-01-16 The Governing Council Of The University Of Toronto Uso de SFRP-3 en la evaluación de la insuficiencia cardíaca
WO2011012268A1 (en) 2009-07-27 2011-02-03 Roche Diagnostics Gmbh Use of mimecan in the assessment of heart failure
EP2499489B1 (en) * 2009-11-13 2015-01-07 BG Medicine, Inc. Risk factors and prediction of myocardial infarction
EP2601531A1 (en) 2010-08-04 2013-06-12 IDEXX Laboratories, Inc. Detection of degradation products of canine nt-probnp
EP2715353B1 (en) 2011-05-31 2016-08-24 IDEXX Laboratories, Inc. DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
JP6119607B2 (ja) * 2011-09-20 2017-04-26 コニカミノルタ株式会社 検体希釈用液、それを用いたキットおよび蛍光測定方法
US20140273273A1 (en) 2012-11-01 2014-09-18 Christie Mitchell Ballantyne Biomarkers to improve prediction of heart failure risk
CN103304665A (zh) * 2013-05-21 2013-09-18 上海贝西生物科技有限公司 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用
CN106716135B (zh) * 2014-10-10 2019-03-15 松森昭 用于检测心力衰竭的装置及储存介质
EP3360570A1 (en) 2017-02-13 2018-08-15 Roche Diagnostics GmbH Antibodies recognizing genetic variants
EP3657169B1 (en) * 2017-10-02 2023-05-03 Otsuka Pharmaceutical Co., Ltd. Method for detecting analyte
CN108752480B (zh) * 2018-05-30 2022-03-29 中元汇吉生物技术股份有限公司 一种免疫原组合物、其制备方法及其用途
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
CN111487222B (zh) * 2019-01-28 2023-11-14 上海乐合生物科技有限公司 一种检测bnp的spr芯片的制备方法
CN114207444A (zh) 2019-08-13 2022-03-18 挪威金田有限公司 用于NT-proBNP定量的高灵敏度颗粒增强测定
EP4222499A1 (en) 2020-09-30 2023-08-09 F. Hoffmann-La Roche AG Circulating total-nt-probnp (glycosylated and unglycosylated nt-probnp) and its ratio with nt-probnp (unglycosylated nt-probnp) in the assessment of atrial fibrillation
CN112964885B (zh) * 2021-02-20 2022-11-11 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
CN112986586A (zh) * 2021-02-20 2021-06-18 广东菲鹏生物有限公司 一种氨基末端脑尿钠肽检测方法和试剂盒
IL311792A (en) 2021-10-01 2024-05-01 Gentian As A new method for determining the concentration of N-terminal prohormone BNP (NT-PROBNP) in a sample
WO2023175152A1 (en) 2022-03-18 2023-09-21 Roche Diagnostics Gmbh Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction
WO2023175176A1 (en) 2022-03-18 2023-09-21 Roche Diagnostics Gmbh Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
JP2665850B2 (ja) 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
GB9827348D0 (en) 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
CN101046478B (zh) 1999-01-29 2013-04-03 罗赫诊断器材股份有限公司 鉴定样品中的n-末端前bnp的方法
US20030219734A1 (en) 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US20040096919A1 (en) * 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
ES2372282T3 (es) * 2003-05-12 2012-01-18 F. Hoffmann-La Roche Ag Método para detectar probnp con un anticuerpo monoclonal que fija los aminoácidos 38-43.

Also Published As

Publication number Publication date
EP1625164A1 (en) 2006-02-15
HUE025169T2 (en) 2016-02-29
JP2010011860A (ja) 2010-01-21
KR20060003905A (ko) 2006-01-11
CN1784425A (zh) 2006-06-07
CA2522747A1 (en) 2004-11-18
EP1625163B1 (en) 2011-08-31
ES2369008T3 (es) 2011-11-24
EP1625163A1 (en) 2006-02-15
HK1097855A1 (en) 2007-07-06
ATE522546T1 (de) 2011-09-15
CN100497393C (zh) 2009-06-10
EP2256132B1 (en) 2015-04-01
JP5128125B2 (ja) 2013-01-23
CA2522378A1 (en) 2004-11-18
WO2004099253A1 (en) 2004-11-18
JP2007535470A (ja) 2007-12-06
BRPI0410261B1 (pt) 2020-03-10
EP2949669A1 (en) 2015-12-02
DK2256132T3 (en) 2015-07-13
BRPI0410261B8 (pt) 2021-07-27
ATE517124T1 (de) 2011-08-15
EP1625163B8 (en) 2011-11-02
WO2004099252A1 (en) 2004-11-18
US7807380B2 (en) 2010-10-05
PL2256132T3 (pl) 2016-08-31
CA2522378C (en) 2011-03-29
DK1625164T3 (da) 2011-10-31
BRPI0410261A (pt) 2006-05-16
ES2372282T3 (es) 2012-01-18
CA2522747C (en) 2012-08-14
CN1832964A (zh) 2006-09-13
AU2004235974B2 (en) 2008-02-14
US7264939B2 (en) 2007-09-04
ES2548327T3 (es) 2015-10-15
US20060110775A1 (en) 2006-05-25
US7264938B2 (en) 2007-09-04
JP4834136B2 (ja) 2011-12-14
US20070099241A1 (en) 2007-05-03
US20070117156A1 (en) 2007-05-24
JP4430066B2 (ja) 2010-03-10
PL1625163T3 (pl) 2012-01-31
JP5649631B2 (ja) 2015-01-07
DK1625163T3 (da) 2011-12-05
KR100857752B1 (ko) 2008-09-11
KR20080011467A (ko) 2008-02-04
JP2007525427A (ja) 2007-09-06
JP2013018784A (ja) 2013-01-31
PL1625164T3 (pl) 2011-12-30
CN101967190A (zh) 2011-02-09
AU2004235974A1 (en) 2004-11-18
EP1625164B1 (en) 2011-07-20
US7811770B2 (en) 2010-10-12
US20060110776A1 (en) 2006-05-25
EP2256132A1 (en) 2010-12-01

Similar Documents

Publication Publication Date Title
MXPA05011826A (es) Metodo para detectar probnp con un anticuerpo monoclonal que se enlaza a los aminoacidos 41-46.
MX337991B (es) Metodo para detectar cancer.
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
NZ595340A (en) Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
NZ603492A (en) Humanized anti-factor d antibodies and uses thereof
UA94576C2 (ru) Выделенное антитело, которое связывается с igf-1r, композиция, которая его содержит, и способы, которые касаются антител
ATE486093T1 (de) Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt
WO2009004822A1 (ja) 抗Muc17抗体
MX2009009450A (es) Anticuerpos monoclonales para he4 y metodos para su uso.
WO2006116442A3 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
WO2008012362A3 (en) New protein isoforms and uses thereof
TW200740842A (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
HK1080091A1 (zh) 用於單獨測定scca同形異構體的免疫測定法
WO2009054091A1 (ja) ガストリン放出ペプチド前駆体に対する抗体及びその使用
WO2009051427A3 (en) A kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same
WO2012112013A3 (en) A marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer
WO2008136510A1 (ja) 自己免疫性膵炎及び劇症１型糖尿病の検査方法及び検査試薬
WO2009044561A1 (ja) 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体
WO2009045075A3 (en) A monoclonal antibody specific to human embryonic stem cell, a hybridoma secreting the same and a method for detecting or isolating non-differenced embryonic stem cell
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
EP1359161A3 (en) Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof
WO2004029094B1 (en) Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3
WO2009031351A1 (ja) ウイルス抗原の検出方法及びウイルス抗原の検出キット

Legal Events

Date Code Title Description
FG Grant or registration